The Experts below are selected from a list of 2499 Experts worldwide ranked by ideXlab platform
Murray B. Urowitz - One of the best experts on this subject based on the ideXlab platform.
-
prognostic implications of active discoid lupus erythematosus and Malar Rash at the time of diagnosis of systemic lupus erythematosus results from a prospective cohort study
Lupus, 2016Co-Authors: Aaron M. Drucker, Dafna D. Gladman, Farheen Mussani, Sanjay Siddha, Murray B. UrowitzAbstract:ObjectiveCutaneous lupus erythematosus (CLE) may have prognostic implications for systemic lupus erythematosus (SLE). We aimed to determine the impact of discoid lupus erythematosus (DLE) and Malar Rash on SLE disease activity.MethodsData were analyzed from the Toronto Lupus Clinic prospective cohort study. We compared SLE patients with active DLE or Malar Rash at SLE diagnosis to SLE patients who never developed CLE. Outcomes were assessed at one and five years, including Adjusted Mean Systemic Lupus Erythematosus Disease Activity Index 2000 (AMS).ResultsA total of 524 SLE patients (284 without CLE, 65 with DLE, and 175 with Malar Rash) were included. Mean AMS scores in patients without CLE at one and five years were 5.96 ± 5.06 and 4.00 ± 3.52, which did not differ significantly from scores at one (6.93 ± 5.31, p = 0.17) and five years (4.29 ± 2.62, p = 0.63) in the DLE group. In patients with Malar Rash, AMS scores at one (8.30 ± 6.80, p < 0.001) and five years (5.23 ± 3.06, p = 0.004) were higher than...
-
Prognostic implications of active discoid lupus erythematosus and Malar Rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study.
Lupus, 2015Co-Authors: Aaron M. Drucker, Dafna D. Gladman, Farheen Mussani, Sanjay Siddha, Murray B. UrowitzAbstract:ObjectiveCutaneous lupus erythematosus (CLE) may have prognostic implications for systemic lupus erythematosus (SLE). We aimed to determine the impact of discoid lupus erythematosus (DLE) and Malar Rash on SLE disease activity.MethodsData were analyzed from the Toronto Lupus Clinic prospective cohort study. We compared SLE patients with active DLE or Malar Rash at SLE diagnosis to SLE patients who never developed CLE. Outcomes were assessed at one and five years, including Adjusted Mean Systemic Lupus Erythematosus Disease Activity Index 2000 (AMS).ResultsA total of 524 SLE patients (284 without CLE, 65 with DLE, and 175 with Malar Rash) were included. Mean AMS scores in patients without CLE at one and five years were 5.96 ± 5.06 and 4.00 ± 3.52, which did not differ significantly from scores at one (6.93 ± 5.31, p = 0.17) and five years (4.29 ± 2.62, p = 0.63) in the DLE group. In patients with Malar Rash, AMS scores at one (8.30 ± 6.80, p
Aaron M. Drucker - One of the best experts on this subject based on the ideXlab platform.
-
prognostic implications of active discoid lupus erythematosus and Malar Rash at the time of diagnosis of systemic lupus erythematosus results from a prospective cohort study
Lupus, 2016Co-Authors: Aaron M. Drucker, Dafna D. Gladman, Farheen Mussani, Sanjay Siddha, Murray B. UrowitzAbstract:ObjectiveCutaneous lupus erythematosus (CLE) may have prognostic implications for systemic lupus erythematosus (SLE). We aimed to determine the impact of discoid lupus erythematosus (DLE) and Malar Rash on SLE disease activity.MethodsData were analyzed from the Toronto Lupus Clinic prospective cohort study. We compared SLE patients with active DLE or Malar Rash at SLE diagnosis to SLE patients who never developed CLE. Outcomes were assessed at one and five years, including Adjusted Mean Systemic Lupus Erythematosus Disease Activity Index 2000 (AMS).ResultsA total of 524 SLE patients (284 without CLE, 65 with DLE, and 175 with Malar Rash) were included. Mean AMS scores in patients without CLE at one and five years were 5.96 ± 5.06 and 4.00 ± 3.52, which did not differ significantly from scores at one (6.93 ± 5.31, p = 0.17) and five years (4.29 ± 2.62, p = 0.63) in the DLE group. In patients with Malar Rash, AMS scores at one (8.30 ± 6.80, p < 0.001) and five years (5.23 ± 3.06, p = 0.004) were higher than...
-
Prognostic implications of active discoid lupus erythematosus and Malar Rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study.
Lupus, 2015Co-Authors: Aaron M. Drucker, Dafna D. Gladman, Farheen Mussani, Sanjay Siddha, Murray B. UrowitzAbstract:ObjectiveCutaneous lupus erythematosus (CLE) may have prognostic implications for systemic lupus erythematosus (SLE). We aimed to determine the impact of discoid lupus erythematosus (DLE) and Malar Rash on SLE disease activity.MethodsData were analyzed from the Toronto Lupus Clinic prospective cohort study. We compared SLE patients with active DLE or Malar Rash at SLE diagnosis to SLE patients who never developed CLE. Outcomes were assessed at one and five years, including Adjusted Mean Systemic Lupus Erythematosus Disease Activity Index 2000 (AMS).ResultsA total of 524 SLE patients (284 without CLE, 65 with DLE, and 175 with Malar Rash) were included. Mean AMS scores in patients without CLE at one and five years were 5.96 ± 5.06 and 4.00 ± 3.52, which did not differ significantly from scores at one (6.93 ± 5.31, p = 0.17) and five years (4.29 ± 2.62, p = 0.63) in the DLE group. In patients with Malar Rash, AMS scores at one (8.30 ± 6.80, p
Farheen Mussani - One of the best experts on this subject based on the ideXlab platform.
-
prognostic implications of active discoid lupus erythematosus and Malar Rash at the time of diagnosis of systemic lupus erythematosus results from a prospective cohort study
Lupus, 2016Co-Authors: Aaron M. Drucker, Dafna D. Gladman, Farheen Mussani, Sanjay Siddha, Murray B. UrowitzAbstract:ObjectiveCutaneous lupus erythematosus (CLE) may have prognostic implications for systemic lupus erythematosus (SLE). We aimed to determine the impact of discoid lupus erythematosus (DLE) and Malar Rash on SLE disease activity.MethodsData were analyzed from the Toronto Lupus Clinic prospective cohort study. We compared SLE patients with active DLE or Malar Rash at SLE diagnosis to SLE patients who never developed CLE. Outcomes were assessed at one and five years, including Adjusted Mean Systemic Lupus Erythematosus Disease Activity Index 2000 (AMS).ResultsA total of 524 SLE patients (284 without CLE, 65 with DLE, and 175 with Malar Rash) were included. Mean AMS scores in patients without CLE at one and five years were 5.96 ± 5.06 and 4.00 ± 3.52, which did not differ significantly from scores at one (6.93 ± 5.31, p = 0.17) and five years (4.29 ± 2.62, p = 0.63) in the DLE group. In patients with Malar Rash, AMS scores at one (8.30 ± 6.80, p < 0.001) and five years (5.23 ± 3.06, p = 0.004) were higher than...
-
Prognostic implications of active discoid lupus erythematosus and Malar Rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study.
Lupus, 2015Co-Authors: Aaron M. Drucker, Dafna D. Gladman, Farheen Mussani, Sanjay Siddha, Murray B. UrowitzAbstract:ObjectiveCutaneous lupus erythematosus (CLE) may have prognostic implications for systemic lupus erythematosus (SLE). We aimed to determine the impact of discoid lupus erythematosus (DLE) and Malar Rash on SLE disease activity.MethodsData were analyzed from the Toronto Lupus Clinic prospective cohort study. We compared SLE patients with active DLE or Malar Rash at SLE diagnosis to SLE patients who never developed CLE. Outcomes were assessed at one and five years, including Adjusted Mean Systemic Lupus Erythematosus Disease Activity Index 2000 (AMS).ResultsA total of 524 SLE patients (284 without CLE, 65 with DLE, and 175 with Malar Rash) were included. Mean AMS scores in patients without CLE at one and five years were 5.96 ± 5.06 and 4.00 ± 3.52, which did not differ significantly from scores at one (6.93 ± 5.31, p = 0.17) and five years (4.29 ± 2.62, p = 0.63) in the DLE group. In patients with Malar Rash, AMS scores at one (8.30 ± 6.80, p
Sanjay Siddha - One of the best experts on this subject based on the ideXlab platform.
-
prognostic implications of active discoid lupus erythematosus and Malar Rash at the time of diagnosis of systemic lupus erythematosus results from a prospective cohort study
Lupus, 2016Co-Authors: Aaron M. Drucker, Dafna D. Gladman, Farheen Mussani, Sanjay Siddha, Murray B. UrowitzAbstract:ObjectiveCutaneous lupus erythematosus (CLE) may have prognostic implications for systemic lupus erythematosus (SLE). We aimed to determine the impact of discoid lupus erythematosus (DLE) and Malar Rash on SLE disease activity.MethodsData were analyzed from the Toronto Lupus Clinic prospective cohort study. We compared SLE patients with active DLE or Malar Rash at SLE diagnosis to SLE patients who never developed CLE. Outcomes were assessed at one and five years, including Adjusted Mean Systemic Lupus Erythematosus Disease Activity Index 2000 (AMS).ResultsA total of 524 SLE patients (284 without CLE, 65 with DLE, and 175 with Malar Rash) were included. Mean AMS scores in patients without CLE at one and five years were 5.96 ± 5.06 and 4.00 ± 3.52, which did not differ significantly from scores at one (6.93 ± 5.31, p = 0.17) and five years (4.29 ± 2.62, p = 0.63) in the DLE group. In patients with Malar Rash, AMS scores at one (8.30 ± 6.80, p < 0.001) and five years (5.23 ± 3.06, p = 0.004) were higher than...
-
Prognostic implications of active discoid lupus erythematosus and Malar Rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study.
Lupus, 2015Co-Authors: Aaron M. Drucker, Dafna D. Gladman, Farheen Mussani, Sanjay Siddha, Murray B. UrowitzAbstract:ObjectiveCutaneous lupus erythematosus (CLE) may have prognostic implications for systemic lupus erythematosus (SLE). We aimed to determine the impact of discoid lupus erythematosus (DLE) and Malar Rash on SLE disease activity.MethodsData were analyzed from the Toronto Lupus Clinic prospective cohort study. We compared SLE patients with active DLE or Malar Rash at SLE diagnosis to SLE patients who never developed CLE. Outcomes were assessed at one and five years, including Adjusted Mean Systemic Lupus Erythematosus Disease Activity Index 2000 (AMS).ResultsA total of 524 SLE patients (284 without CLE, 65 with DLE, and 175 with Malar Rash) were included. Mean AMS scores in patients without CLE at one and five years were 5.96 ± 5.06 and 4.00 ± 3.52, which did not differ significantly from scores at one (6.93 ± 5.31, p = 0.17) and five years (4.29 ± 2.62, p = 0.63) in the DLE group. In patients with Malar Rash, AMS scores at one (8.30 ± 6.80, p
Dafna D. Gladman - One of the best experts on this subject based on the ideXlab platform.
-
prognostic implications of active discoid lupus erythematosus and Malar Rash at the time of diagnosis of systemic lupus erythematosus results from a prospective cohort study
Lupus, 2016Co-Authors: Aaron M. Drucker, Dafna D. Gladman, Farheen Mussani, Sanjay Siddha, Murray B. UrowitzAbstract:ObjectiveCutaneous lupus erythematosus (CLE) may have prognostic implications for systemic lupus erythematosus (SLE). We aimed to determine the impact of discoid lupus erythematosus (DLE) and Malar Rash on SLE disease activity.MethodsData were analyzed from the Toronto Lupus Clinic prospective cohort study. We compared SLE patients with active DLE or Malar Rash at SLE diagnosis to SLE patients who never developed CLE. Outcomes were assessed at one and five years, including Adjusted Mean Systemic Lupus Erythematosus Disease Activity Index 2000 (AMS).ResultsA total of 524 SLE patients (284 without CLE, 65 with DLE, and 175 with Malar Rash) were included. Mean AMS scores in patients without CLE at one and five years were 5.96 ± 5.06 and 4.00 ± 3.52, which did not differ significantly from scores at one (6.93 ± 5.31, p = 0.17) and five years (4.29 ± 2.62, p = 0.63) in the DLE group. In patients with Malar Rash, AMS scores at one (8.30 ± 6.80, p < 0.001) and five years (5.23 ± 3.06, p = 0.004) were higher than...
-
Prognostic implications of active discoid lupus erythematosus and Malar Rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study.
Lupus, 2015Co-Authors: Aaron M. Drucker, Dafna D. Gladman, Farheen Mussani, Sanjay Siddha, Murray B. UrowitzAbstract:ObjectiveCutaneous lupus erythematosus (CLE) may have prognostic implications for systemic lupus erythematosus (SLE). We aimed to determine the impact of discoid lupus erythematosus (DLE) and Malar Rash on SLE disease activity.MethodsData were analyzed from the Toronto Lupus Clinic prospective cohort study. We compared SLE patients with active DLE or Malar Rash at SLE diagnosis to SLE patients who never developed CLE. Outcomes were assessed at one and five years, including Adjusted Mean Systemic Lupus Erythematosus Disease Activity Index 2000 (AMS).ResultsA total of 524 SLE patients (284 without CLE, 65 with DLE, and 175 with Malar Rash) were included. Mean AMS scores in patients without CLE at one and five years were 5.96 ± 5.06 and 4.00 ± 3.52, which did not differ significantly from scores at one (6.93 ± 5.31, p = 0.17) and five years (4.29 ± 2.62, p = 0.63) in the DLE group. In patients with Malar Rash, AMS scores at one (8.30 ± 6.80, p
